Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C5H11NO · HCl
CAS Number:
Molecular Weight:
137.61
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
226-374-7
Beilstein/REAXYS Number:
3908995
MDL number:
Assay:
98%
assay
98%
mp
155-157 °C (lit.)
solubility
methanol: soluble 25 mg/mL, clear, colorless
functional group
hydroxyl
SMILES string
Cl[H].OC1CCNCC1
InChI
1S/C5H11NO.ClH/c7-5-1-3-6-4-2-5;/h5-7H,1-4H2;1H
InChI key
VKCORPXOKYDINR-UHFFFAOYSA-N
General description
4-Hydroxypiperidine hydrochloride is a piperidine derivative. The synthesis of 4-hydroxypiperidine has been reported. 4-Hydroxypiperidine participates in the synthesis of 4-(4′-hydroxypiperidino)-4-phenylcyclohexanol and 1-(4-hydroxypiperidino)cyclohexanecarbonitrile. 4-Hydroxypiperidine is the starting material for the synthesis of Sibrafiban and Lamifiban, two non-peptidefibrinogen receptor.
Application
4-Hydroxypiperidine hydrochloride is suitable for use in the Ugi-multi component reaction (MCR) to study the use of miniaturised-synthesis and Total Analysis System (mSYNTAS) in solution phase synthesis and on-line analysis of Ugi-MCRs. It may be used in the synthesis of acetic acid-piperidine-4-yl ester.
Reactant for synthesis of:
14C-labeled E4010
PET tracer for imaging brain acetylcholinesterase
Reactant for allosteric modulators of metabotropic glutamate receptor subtype 5
14C-labeled E4010
PET tracer for imaging brain acetylcholinesterase
Reactant for allosteric modulators of metabotropic glutamate receptor subtype 5
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
